Additional Information
Size: |
100 µg |
Target: |
STK4 |
Conjugate: |
Dylight 488 |
Research Area: |
Cell Signaling | Protein Phosphorylation | Serine / Threonine Kinases | Cardiovascular System | Atherosclerosis | Heart | Hypertrophy |
Alternative Name: |
Serine/threonine-protein kinase 4 Antibody, YSK3 Antibody, STE20-like kinase MST1 Antibody, MST-1 Antibody, Mammalian sterile 20 like 1 Antibody, TIIAC Antibody, MST1 Antibody, Krs2 Antibody, Mammalian STE20 like protein kinase 1 Antibody, EC:2.7.11. |
Category: |
Antibodies |
Product Type: |
Polyclonal Antibody |
Immunogen: |
Synthetic peptide from the C-terminal of Human Serine/threonine-protein kinase 4 (aa. 320-420) |
Immunogen Species: |
Human |
Applications: |
WB, IHC |
Host: |
Rabbit |
Isotype: |
N/A |
Species Reactivity: |
Human |
Antibody Dilution: |
WB (1:1000); IHC (1:50); optimal dilutions for assays should be determined by the user. |
Purification: |
Peptide Affinity Purified |
Storage Buffer: |
PBS pH 7.4, 50% glycerol, 0.09% Sodium Azide |
Concentration: |
1 mg/ml |
Specificity: |
Detects 55 kDa. |
Storage: |
-20ºC |
Shipping: |
Blue Ice or 4ºC |
Certificate of Analysis: |
A 1:1000 dilution of SPC-794 was sufficient for detection of STK4 in 10 μg of human HeLa cell lysates by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody. |
Cellular Localization: |
Cytoplasm, Nucleus |
Tissue Specificity: |
Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Ubiquitously expressed. |
Accession Number: |
NP_006273.1 |
Gene ID: |
6789 |
Swiss-Prot: |
Q13043 |
Field of Use: |
For in vitro research use only. |